Following the EMBL model, EMBL Australia group leaders are given the freedom and funding to pursue ambitious research, ask big questions and take big risks.
The EMBL Australia Partner Laboratory Network (PLN) currently consists of 15 research groups at six institutes across the nation. The secretariat is hosted at Monash University.
The Victorian node of the PLN is hosted at Monash University and currently consists of six research groups:
Chen Davidovich, based at the Monash Biomedicine Discovery Institute (Monash BDI), is studying key proteins involved in the maintenance of stem cell fate, which play an important role in multiple cancers.
Max Cryle, also based at Monash BDI, is using a combination of techniques to understand and harness the major protein machines that catalyse the production of some of the most important antibiotics in clinical use.
Mikaël Martino, based at ARMI, focuses on the immune regulation of stem cells and regeneration, seeking to design regenerative medicine strategies integrating a control of the immune system.
Harald Janovjak, also based at ARMI, aims to develop synthetic biology strategies to maintain cell survival and initiate cell proliferation in degenerative disorders.
Senthil Arumugam, based at Monash BDI, researches how complex properties arise out of molecules and their interactions, with a primary focus on endosomal trafficking.
South Australian node
The South Australian node of the PLN is hosted at the South Australian Health and Medical Research Institute (SAHMRI) and comprises three groups, supported by the University of Adelaide, the University of South Australia and Flinders University.
David Lynn is based at the SAHMRI Infection and Immunity theme, where he investigates the regulation of the innate immune system from a genome-wide or systems-level perspective.
Ville-Petteri Mäkinen is based at the Heart Health research theme at SAHMRI, where he uses big data to better understand pathologic phenomena at the intersection of ageing, obesity, diabetes and cardiovascular disease.
New South Wales node
The New South Wales node of the PLN is hosted at the University of New South Wales (UNSW) and the Garvan Institute of Medical Research, Sydney.
Yann Gambin is based at UNSW’s Centre in Single Molecule Science. He combines single molecule detection and microfluidics to develop a microscopy-based pipeline to readily study protein-protein interactions at high resolution.
Maté Biro is also based at the UNSW Centre in Single Molecule Science. He studies actomyosin mechanisms during cytoxic T cell action and the elucidation of the biomechanical cell-cell interaction between T cells and their cancerous targets.
Robert Weatheritt is based at the Garvan Institute and aims to understand how post-transcriptional regulation contributes to proteomic diversity and cell signalling.
Richard Morris is based at UNSW’s Centre in Single Molecule Science. He applies and develops concepts from statistical and theoretical soft-condensed matter physics, as well as applied mathematics, in order to describe biological systems.
Vaishnavi Ananthanarayanan is also based at UNSW’s Centre in Single Molecule Science. She investigates how stochastic and rare events, such as motor protein binding to cytoskeletal tracks or cargo, give rise to complex cellular organisation across scales.
Australian Capital Territory node
The ACT node of the PLN is hosted at the Australian National University (ANU), Canberra.
Barry Thompson is based at the John Curtin School of Medical Research at ANU and aims to understand the control of tissue growth and form using Drosophila and mice as models.
Eduardo Eyras, also based at the John Curtin School of Medical Research at ANU, is working on understanding the biology of RNA and cancer using computational methods.
The Queensland node of the PLN is hosted at the QIMR Berghofer Medical Research Institute.
Michelle Boyle is based at QIMR Berghofer. Her goal is to inform the development of effectivemalaria vaccines by defining functional mechanisms of antibodies that target the parasite, and the development of protective antibodies in humans.
Though not officially part of the PLN, a number of research groups have strong and direct collaborative links between Australia and EMBL scientists.